Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18052564 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain
Condition: Depressive Disorder, Major
Interventions: Drug: Duloxetine Hydrochloride;   Drug: Placebo

Indicates status has not been verified in more than two years